<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<DIV STYLE="border-top: Black 2pt double; border-bottom: Black 2pt double">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>SECURITIES
AND EXCHANGE COMMISSION<BR>
</B></FONT><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>FORM 8-K<BR>
<BR>
</B></FONT><B>Current Report<BR>
<BR>
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>April 5, 2012 (April 3, 2012)<BR>
</B>Date of Report (Date of earliest event reported)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>MEDGENICS, INC.<BR>
</B>(Exact name of registrant as specified in its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 34%; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold; text-align: center"><B>Delaware</B></TD>
    <TD STYLE="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold; text-align: center"><B>1-35112</B></TD>
    <TD STYLE="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold; text-align: center"><B>98-0217544</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">(State or other jurisdiction of<BR>
incorporation or organization)</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">(Commission File Number)</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">(I.R.S. Employer<BR>
Identification No.)</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>555 California Street, Suite 365</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>San Francisco, California 94104</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive offices,
zip code)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(415) 568-2245<BR>
</B>(Registrant&rsquo;s telephone number, including area code)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Not Applicable<BR>
(Former name or former address, if changed since last report)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><BR>
&#9;Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2. below):<BR STYLE="mso-special-character: line-break">
<BR STYLE="mso-special-character: line-break">
</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; text-align: center"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="width: 96%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD>Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD>Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD>Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;&nbsp;</P>

</DIV>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 50%">&nbsp;</TD><TD STYLE="text-align: right; width: 50%"></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in"></P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in"><B>Item 5.02.</B></TD><TD><B>Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
of Certain Officers.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">On March 5, 2012, upon the recommendation
of the Compensation Committee, the Board of Directors of Medgenics, Inc., a Delaware corporation (the &ldquo;Company&rdquo;), approved
the amendment and restatement of the Company&rsquo;s 2006 Stock Incentive Plan (the &ldquo;Incentive Plan&rdquo;), subject to stockholder
approval. The amendment and restatement of the Incentive Plan was approved by stockholders at the Company&rsquo;s Annual Meeting
of Stockholders on April 3, 2012. The amendment and restatement of the Incentive Plan increased the number of shares available
for issuance by 750,000 shares, extended the term of the Incentive Plan and made certain other changes described in the proxy materials
relating to the meeting. A copy of the amended and restated Incentive Plan is attached hereto as Exhibit 10.1 and incorporated
into this Item 5.02 by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in"><B>Item 5.07.</B></TD><TD><B>Submission of Matters to a Vote of Security Holders.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">On April 3, 2012, the Company held its Annual
Meeting of Stockholders. At the meeting, all seven directors of the Company were elected to serve until the next annual meeting
of stockholders and until their respective successors are duly elected and qualified. Tabulated with the name of each of the nominees
elected is the number of votes cast for each nominee, the number of votes withheld with respect to each nominee and the number
of broker non-votes with respect to each nominee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: baseline">
    <TD STYLE="width: 32%; padding-bottom: 6pt; font-weight: bold; text-align: center"><B>Nominee</B></TD>
    <TD STYLE="width: 22%; padding-bottom: 6pt; font-weight: bold; text-align: center"><B>Votes For</B></TD>
    <TD STYLE="width: 23%; padding-bottom: 6pt; font-weight: bold; text-align: center"><B>Votes Withheld</B></TD>
    <TD STYLE="width: 23%; padding-bottom: 6pt; font-weight: bold; text-align: center"><B>Broker <BR>
Non-Votes</B></TD></TR>
<TR STYLE="vertical-align: baseline">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; padding-left: 0.05in">Eugene A. Bauer</TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: center">2,804,077</TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: center">-0-</TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: center">1,635,600</TD></TR>
<TR STYLE="vertical-align: baseline">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; padding-left: 0.05in">Andrew L. Pearlman</TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: center">2,804,077</TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: center">-0-</TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: center">1,635,600</TD></TR>
<TR STYLE="vertical-align: baseline">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; padding-left: 0.05in">Joel S. Kanter</TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: center">2,804,077</TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: center">-0-</TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: center">1,635,600</TD></TR>
<TR STYLE="vertical-align: baseline">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; padding-left: 0.05in">Gary A. Brukardt</TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: center">2,770,539</TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: center">33,538</TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: center">1,635,600</TD></TR>
<TR STYLE="vertical-align: baseline">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; padding-left: 0.05in">Stephen D. McMurray</TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: center">2,800,077</TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: center">4,000</TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: center">1,635,600</TD></TR>
<TR STYLE="vertical-align: baseline">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; padding-left: 0.05in">Alastair Clemow</TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: center">2,804,077</TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: center">-0-</TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: center">1,635,600</TD></TR>
<TR STYLE="vertical-align: baseline">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; padding-left: 0.05in">Isaac Blech</TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: center">2,803,977</TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: center">100</TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: center">1,635,600</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">In addition, the amendment and restatement
of the Incentive Plan was approved at the meeting with 2,783,620&nbsp;votes in favor, 20,457&nbsp;votes against, no&nbsp;abstentions
and 1,635,600 broker non-votes, and the appointment of Kost Forer Gabbay &amp; Kasierer, a member of Ernst &amp; Young Global,
as the Company&rsquo;s independent registered public accounting firm for the fiscal year ending December&nbsp;31, 2012 was ratified
at the meeting with 4,436,937&nbsp;votes in favor, 100&nbsp;votes against, 2,640&nbsp;abstentions and no broker non-votes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 50%">&nbsp;</TD><TD STYLE="text-align: right; width: 50%"></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><B>Item 9.01 &#9;Financial Statements and
Exhibits.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">(d)</FONT></TD><TD>Exhibits. The following exhibit is filed herewith:<BR STYLE="mso-special-character: line-break">
</TD></TR>          <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: baseline">
    <TD STYLE="width: 13%; padding-right: -0.2in; text-indent: 0in; text-decoration: underline"><U>Exhibit No.</U></TD>
    <TD STYLE="width: 87%; padding-right: -0.2in; text-indent: 0in; text-decoration: underline"><U>Description</U></TD></TR>
<TR STYLE="vertical-align: baseline">
    <TD STYLE="padding-right: -0.2in; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="padding-right: -0.2in; text-indent: 0.7pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: baseline">
    <TD STYLE="padding-right: -0.2in; text-indent: 0in">10.1</TD>
    <TD STYLE="padding-right: -0.2in; text-indent: 0.7pt">Medgenics, Inc. Stock Incentive Plan, as amended and restated effective
    March 5, 2012.</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 50%">&nbsp;</TD><TD STYLE="text-align: right; width: 50%"></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: -2.15pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: -2.15pt">MEDGENICS, INC.</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: -2.15pt; width: 50%">&nbsp;</TD>
    <TD STYLE="padding-right: -2.15pt; width: 3%">&nbsp;</TD>
    <TD STYLE="padding-right: -2.15pt; width: 32%">&nbsp;</TD>
    <TD STYLE="width: 15%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: -2.15pt">&nbsp;</TD>
    <TD STYLE="padding-right: -2.15pt">&nbsp;</TD>
    <TD STYLE="padding-right: -2.15pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: -2.15pt">&nbsp;</TD>
    <TD STYLE="padding-right: -2.15pt">&nbsp;</TD>
    <TD STYLE="padding-right: -2.15pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: -2.15pt">&nbsp;</TD>
    <TD STYLE="padding-right: -2.15pt">By:</TD>
    <TD STYLE="padding-right: -2.15pt; border-bottom: Black 1pt solid">/s/ Phyllis K. Bellin</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: -2.15pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: -2.15pt">Name: Phyllis K. Bellin</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: -2.15pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: -2.15pt">Title: Vice President &ndash; Administration</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date: April 5, 2012</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="margin: 0"></P>

</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "v308666_8-k.htm", "description": "FORM 8-K", "secsgml_size_bytes": 19799}]
{"company-data": {"conformed-name": "MEDGENICS, INC.", "cik": "0001138776", "assigned-sic": "2836", "irs-number": "980217544", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-35112", "film-number": "12744808"}, "business-address": {"street1": "TERADION BUSINESS PK.", "street2": "P.O. BOX 14", "city": "MISGAV", "state": "L3", "zip": "20179", "phone": "1-646-239-1690"}, "mail-address": {"street1": "TERADION BUSINESS PK.", "street2": "P.O. BOX 14", "city": "MISGAV", "state": "L3", "zip": "20179"}, "former-company": {"former-conformed-name": "MEDGENICS INC", "date-changed": "20010419"}}
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington, D.C. 20549
________________________
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
April 5, 2012 (April 3, 2012)
Date of Report (Date of earliest event reported)
MEDGENICS, INC.
(Exact name of registrant as specified in its charter)
Delaware
1-35112
98-0217544
(State or other jurisdiction of
incorporation or organization)
(Commission File Number)
(I.R.S. Employer
Identification No.)
555 California Street, Suite 365
San Francisco, California 94104
(Address of principal executive offices,
zip code)
(415) 568-2245
(Registrant's telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2. below):
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
of Certain Officers.
On March 5, 2012, upon the recommendation
of the Compensation Committee, the Board of Directors of Medgenics, Inc., a Delaware corporation (the "Company"), approved
the amendment and restatement of the Company's 2006 Stock Incentive Plan (the "Incentive Plan"), subject to stockholder
approval. The amendment and restatement of the Incentive Plan was approved by stockholders at the Company's Annual Meeting
of Stockholders on April 3, 2012. The amendment and restatement of the Incentive Plan increased the number of shares available
for issuance by 750,000 shares, extended the term of the Incentive Plan and made certain other changes described in the proxy materials
relating to the meeting. A copy of the amended and restated Incentive Plan is attached hereto as Exhibit 10.1 and incorporated
into this Item 5.02 by reference.
Item 5.07.
Submission of Matters to a Vote of Security Holders.
On April 3, 2012, the Company held its Annual
Meeting of Stockholders. At the meeting, all seven directors of the Company were elected to serve until the next annual meeting
of stockholders and until their respective successors are duly elected and qualified. Tabulated with the name of each of the nominees
elected is the number of votes cast for each nominee, the number of votes withheld with respect to each nominee and the number
of broker non-votes with respect to each nominee.
Nominee
Votes For
Votes Withheld
Broker
Non-Votes
Eugene A. Bauer
2,804,077
-0-
1,635,600
Andrew L. Pearlman
2,804,077
-0-
1,635,600
Joel S. Kanter
2,804,077
-0-
1,635,600
Gary A. Brukardt
2,770,539
33,538
1,635,600
Stephen D. McMurray
2,800,077
4,000
1,635,600
Alastair Clemow
2,804,077
-0-
1,635,600
Isaac Blech
2,803,977
100
1,635,600
In addition, the amendment and restatement
of the Incentive Plan was approved at the meeting with 2,783,620 votes in favor, 20,457 votes against, no abstentions
and 1,635,600 broker non-votes, and the appointment of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global,
as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2012 was ratified
at the meeting with 4,436,937 votes in favor, 100 votes against, 2,640 abstentions and no broker non-votes.
Item 9.01 	Financial Statements and
Exhibits.
(d)
Exhibits. The following exhibit is filed herewith:
Exhibit No.
Description
10.1
Medgenics, Inc. Stock Incentive Plan, as amended and restated effective
    March 5, 2012.
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
MEDGENICS, INC.
By:
/s/ Phyllis K. Bellin
Name: Phyllis K. Bellin
Title: Vice President – Administration
Date: April 5, 2012